Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2)

[1]  A. Miyauchi,et al.  Anaplastic Thyroid Carcinomas Incidentally Found on Postoperative Pathological Examination , 2014, World Journal of Surgery.

[2]  F. Khuri,et al.  Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma. , 2014, Thyroid : official journal of the American Thyroid Association.

[3]  R. Smallridge.  Approach to the patient with anaplastic thyroid carcinoma. , 2012, The Journal of clinical endocrinology and metabolism.

[4]  I. Sugitani.  [The anaplastic thyroid carcinoma research consortium of Japan]. , 2012, Nihon Geka Gakkai zasshi.

[5]  A. Miyauchi,et al.  Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients , 2012, World Journal of Surgery.

[6]  Kunihiko Ito,et al.  Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. , 2011, Thyroid : official journal of the American Thyroid Association.

[7]  I. Sugitani,et al.  A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report. , 2011, Japanese journal of clinical oncology.

[8]  Y. Ando,et al.  The feasibility study of docetaxel in patients with anaplastic thyroid cancer. , 2010, Japanese journal of clinical oncology.

[9]  M. Hirokawa,et al.  Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. , 2010, Thyroid : official journal of the American Thyroid Association.

[10]  E. Kebebew,et al.  Anaplastic thyroid carcinoma , 2005, Cancer.

[11]  G. Thompson,et al.  Anaplastic thyroid carcinoma: a 50-year experience at a single institution. , 2001, Surgery.

[12]  I. Sugitani,et al.  Prognostic Factors and Therapeutic Strategy for Anaplastic Carcinoma of the Thyroid , 2001, World Journal of Surgery.

[13]  M. Egorin,et al.  Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. , 2000, Thyroid : official journal of the American Thyroid Association.

[14]  Y. Nikiforov,et al.  American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[15]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.